Profile
KZIA VRTX REGN VRNA ARGX ALNY
Company Name Kazia Therapeutics Limited Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $8.84M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO John Edwin Friend Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
KZIA VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
KZIA VRTX REGN VRNA ARGX ALNY
Last Close $6.0819 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $11.5 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.69 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -47.11 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 781.43 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
KZIA VRTX REGN VRNA ARGX ALNY
1 Month Return -13.12 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -18.03 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 69.41 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 575.77 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 243.61 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 6.51 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
KZIA VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2.02 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
KZIA VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 100 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -336.66 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 337.03 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 177.89 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 90.9 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 157.9 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -33850 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -2109.23 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 0.47 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 0.69 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -5.38 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -2.71 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 279.68 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -19887.06 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 50.41 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -2109.23 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -2.95 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -1.43 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -1.43 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
KZIA VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 100% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.01B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.02B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -18.9 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
KZIA VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.01B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $-0.01B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.01B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
KZIA VRTX REGN VRNA ARGX ALNY
Net Income $-0.02B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
Unlock